{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:42:43Z","timestamp":1769236963744,"version":"3.49.0"},"reference-count":43,"publisher":"American Psychiatric Association Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2001,9,1]]},"DOI":"10.1176\/appi.ajp.158.9.1411","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:20:39Z","timestamp":1034360439000},"page":"1411-1422","source":"Crossref","is-referenced-by-count":159,"title":["Lamina-Specific Deficits in Parvalbumin-Immunoreactive Varicosities in the Prefrontal Cortex of Subjects With Schizophrenia: Evidence for Fewer Projections From the Thalamus"],"prefix":"10.1176","volume":"158","author":[{"given":"David A.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne A.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene S.","family":"Melchitzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph N.","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1589CIHCJFFG","doi-asserted-by":"crossref","unstructured":"Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M: Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999; 156:1328-1335","DOI":"10.1176\/ajp.156.9.1328"},{"key":"R1589CIHHIBIB","doi-asserted-by":"crossref","unstructured":"Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330","DOI":"10.1176\/ajp.153.3.321"},{"key":"R1589CIHHJEII","doi-asserted-by":"crossref","unstructured":"Weinberger DR, Berman KF, Zec RF: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43:114-124","DOI":"10.1001\/archpsyc.1986.01800020020004"},{"key":"R1589CIHIAIAB","doi-asserted-by":"crossref","unstructured":"Goldman-Rakic PS: Working memory dysfunction in schizophrenia. J Neuropsychiatry 1994; 6:348-357","DOI":"10.1176\/jnp.6.4.348"},{"key":"R1589CIHCJDEI","doi-asserted-by":"crossref","unstructured":"Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, Tourville J, Caviness VS, Faraone SV, Tsuang MT: Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 1999; 56:537-547","DOI":"10.1001\/archpsyc.56.6.537"},{"key":"R1589CIHIHAIG","doi-asserted-by":"crossref","unstructured":"Glantz LA, Lewis DA: Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Gen Psychiatry 1997; 54:943-952","DOI":"10.1001\/archpsyc.1997.01830220065010"},{"key":"R1589CIHDHEEF","doi-asserted-by":"crossref","unstructured":"Selemon LD, Goldman-Rakic PS: The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999; 45:17-25","DOI":"10.1016\/S0006-3223(98)00281-9"},{"key":"R1589CIHEEJBE","doi-asserted-by":"crossref","unstructured":"Giguere M, Goldman-Rakic PS: Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J Comp Neurol 1988; 277:195-213","DOI":"10.1002\/cne.902770204"},{"key":"R1589CIHFEADC","doi-asserted-by":"crossref","unstructured":"Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O\u2019Leary D, Ehrhardt JC, Yuh WTC: Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298","DOI":"10.1126\/science.7939669"},{"key":"R1589CIHFJFEJ","doi-asserted-by":"crossref","unstructured":"Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE Jr: PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996; 153:191-199","DOI":"10.1176\/ajp.153.2.191"},{"key":"R1589CIHCJACG","doi-asserted-by":"crossref","unstructured":"Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028","DOI":"10.1001\/archpsyc.1990.01810230039007"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Young KA, Manaye KF, Liang C-L, Hicks PB, German DC: Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 2000; 47:944-953","DOI":"10.1016\/S0006-3223(00)00826-X"},{"key":"R1589CIHJJCHI","doi-asserted-by":"crossref","unstructured":"Popken GJ, Bunney WE Jr, Potkin SG, Jones EG: Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci USA 2000; 97:9276-9280","DOI":"10.1073\/pnas.150243397"},{"key":"R1589CIHFBBDF","doi-asserted-by":"crossref","unstructured":"Jones EG: Viewpoint: the core and matrix of thalamic organization. Neuroscience 1998; 85:331-345","DOI":"10.1016\/S0306-4522(97)00581-2"},{"key":"R1589CIHDHBGJ","doi-asserted-by":"crossref","unstructured":"Melchitzky DS, Sesack SR, Lewis DA: Parvalbumin-immunoreactive axon terminals in monkey and human prefrontal cortex: laminar, regional and target specificity of type I and type II synapses. J Comp Neurol 1999; 408:11-22","DOI":"10.1002\/(SICI)1096-9861(19990524)408:1<11::AID-CNE2>3.0.CO;2-T"},{"key":"R1589CIHHHAHJ","doi-asserted-by":"crossref","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 1991; 41:479-486","DOI":"10.1212\/WNL.41.4.479"},{"key":"R1589CIHBBBAG","doi-asserted-by":"crossref","unstructured":"Cond\u00e9 F, Lund JS, Lewis DA: The hierarchical development of monkey visual cortical regions as revealed by the maturation of parvalbumin-immunoreactive neurons. Dev Brain Res 1996; 96:261-276","DOI":"10.1016\/0165-3806(96)00126-5"},{"key":"R1589CIHBHIHI","doi-asserted-by":"crossref","unstructured":"Woo T-U, Miller JL, Lewis DA: Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 1997; 154:1013-1015","DOI":"10.1176\/ajp.154.7.1013"},{"key":"R1589CIHEECBJ","doi-asserted-by":"crossref","unstructured":"Daviss SR, Lewis DA: Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 1995; 59:81-96","DOI":"10.1016\/0165-1781(95)02720-3"},{"key":"R1589CIHCADGA","doi-asserted-by":"crossref","unstructured":"Cond\u00e9 F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA: Local circuit neurons immunoreactive for calretinin, calbindin D-28k, or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 1994; 341:95-116","DOI":"10.1002\/cne.903410109"},{"key":"R1589CIHHGCAB","doi-asserted-by":"crossref","unstructured":"Celio MR, Baier W, Sch\u00e4rer L, de Viragh PA, Gerday C: Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium 1988; 9:81-86","DOI":"10.1016\/0143-4160(88)90027-9"},{"key":"R1589CIHBGHBD","doi-asserted-by":"crossref","unstructured":"Pierri JN, Chaudry AS, Woo T-UW, Lewis DA: Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 1999; 156:1709-1719","DOI":"10.1176\/ajp.156.11.1709"},{"key":"R1589CIHIAGHB","doi-asserted-by":"crossref","unstructured":"Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998; 95:5341-5346","DOI":"10.1073\/pnas.95.9.5341"},{"key":"R1589CIHEJEFJ","doi-asserted-by":"crossref","unstructured":"Wiedenmann B, Franke WW: Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 1985; 41:1017-1028","DOI":"10.1016\/S0092-8674(85)80082-9"},{"key":"R1589CIHFBFHD","doi-asserted-by":"crossref","unstructured":"Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA: Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 1999; 156:1580-1589","DOI":"10.1176\/ajp.156.10.1580"},{"key":"R1589CIHGICHA","doi-asserted-by":"crossref","unstructured":"Reyntjens AMJ, Heykants JJP, Gelders YG, Aerts TJL: Pharmacokinetics of haloperidol decanoate: a 2 year follow up. Int Pharmacopsychiatry 1982; 17:238-246","DOI":"10.1159\/000468580"},{"key":"R1589CIHFCJDC","unstructured":"Gray EG: Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscopic study. J Anat 1959; 93:420-433"},{"key":"R1589CIHDJIAC","doi-asserted-by":"crossref","unstructured":"Reynolds GP, Zhang ZJ, Patten I, Beasley CL: Selective deficits of frontal cortical GABAergic neuronal subtypes defined by calcium binding proteins in psychotic illness (abstract). Schizophr Res 2000; 41:255","DOI":"10.1016\/S0920-9964(00)90944-7"},{"key":"R1589CIHIEBGG","doi-asserted-by":"crossref","unstructured":"Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995; 52:258-266","DOI":"10.1001\/archpsyc.1995.03950160008002"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA: Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000; 57:237-245","DOI":"10.1001\/archpsyc.57.3.237"},{"key":"R1589CIHFDHBE","doi-asserted-by":"crossref","unstructured":"Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA: GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 2001; 158:256-265","DOI":"10.1176\/appi.ajp.158.2.256"},{"key":"R1589CIHGFBBI","doi-asserted-by":"crossref","unstructured":"Hazlett EA, Buchsbaum MS, Byne W, Wei T-C, Spiegel-Cohen J, Geneve C, Kinderlehrer R, Haznedar MM, Shihabuddin L, Siever LJ: Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156:1190-1199","DOI":"10.1176\/ajp.156.8.1190"},{"key":"R1589CIHHABJG","doi-asserted-by":"crossref","unstructured":"Heimberg C, Komoroski RA, Lawson WB, Cardwell D, Karson CN: Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res 1998; 83:105-115","DOI":"10.1016\/S0925-4927(98)00034-1"},{"key":"R1589CIHCEEEA","doi-asserted-by":"crossref","unstructured":"Deicken RF, Johnson C, Eliaz Y, Schuff N: Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. Am J Psychiatry 2000; 157:644-647","DOI":"10.1176\/appi.ajp.157.4.644"},{"key":"R1589CIHECDBD","doi-asserted-by":"crossref","unstructured":"Danos P, Baumann B, Bernstein H-G, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B: Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res Neuroimaging 1998; 82:1-10","DOI":"10.1016\/S0925-4927(97)00071-1"},{"key":"R1589CIHFFCGJ","doi-asserted-by":"crossref","unstructured":"Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TRE, Hirsch SR: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65:446-453","DOI":"10.1136\/jnnp.65.4.446"},{"key":"R1589CIHHGGEF","doi-asserted-by":"crossref","unstructured":"Glantz LA, Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57:65-73","DOI":"10.1001\/archpsyc.57.1.65"},{"key":"R1589CIHDHJEF","doi-asserted-by":"crossref","unstructured":"Rajkowska G, Selemon LD, Goldman-Rakic PS: Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55:215-224","DOI":"10.1001\/archpsyc.55.3.215"},{"key":"R1589CIHHGCHG","doi-asserted-by":"crossref","unstructured":"Pierri JN, Volk CLE, Auh S, Sampson A, Lewis DA: Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex in subjects with schizophrenia. Arch Gen Psychiatry 2001; 58:466-473","DOI":"10.1001\/archpsyc.58.5.466"},{"key":"R1589CIHGGCAD","doi-asserted-by":"crossref","unstructured":"Wellman CL, Logue SF, Sengelaub DR: Maze learning and morphology of frontal cortex in adult and aged basal forebrain-lesioned rats. Behav Neurosci 1995; 109:837-850","DOI":"10.1037\/\/0735-7044.109.5.837"},{"key":"R1589CIHDEHJE","doi-asserted-by":"crossref","unstructured":"Lewis DA: Is there a neuropathology of schizophrenia? The Neuroscientist 2000; 6:208-218","DOI":"10.1177\/107385840000600311"},{"key":"R1589CIHJGAGI","doi-asserted-by":"crossref","unstructured":"Jones EG: Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997; 23:483-501","DOI":"10.1093\/schbul\/23.3.483"},{"key":"R1589CIHDHAIG","doi-asserted-by":"crossref","unstructured":"Floresco SB, Braaksma DN, Phillips AG: Thalamic-cortical-striatal circuitry subserves working memory during delayed responding on radial arm maze. J Neurosci 1999; 19:11061-11071","DOI":"10.1523\/JNEUROSCI.19-24-11061.1999"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.9.1411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:05:07Z","timestamp":1721851507000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.9.1411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9,1]]}},"alternative-id":["10.1176\/appi.ajp.158.9.1411"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.158.9.1411","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,1]]}}}